2020Journal of Traditional Chinese Medical SciencesOpen access

Brazilian traditional medicine: Historical basis, features and potentialities for pharmaceutical development

Fernão Castro Braga

Open full text 29 citations

Abstract

This article gives a brief overview on the Brazilian traditional medicine, starting from its historical development based on the cultural mixing of indigenous populations, European colonizers, and African slaves. In the sequence, it analyzes some features that contributed to the gradual loss of interest on medicinal plants in Brazil, a process started in the 1950s, and recent initiatives undertaken to valuate the Brazilian traditional medicine. Furthermore, it highlights some drugs developed from or based on constituents of the Brazilian biodiversity and traditional knowledge, which are globally employed, and the perspectives for new drugs development. It also discusses the sanitary requirements currently adopted in Brazil for the development and registration of medicinal products based on the Brazilian biodiversity and associated traditional knowledge, as well as the impact of new technologies. In addition, it is presented a discussion on the regulatory framework to access to genetic heritage and associated traditional knowledge in Brazil, along with its impact on the development of pharmaceutical products. Finally, some attempts are made to indicate the possible causes that limit the development of products based on the genetic heritage of Brazilian plants and associated traditional knowledge.

Open-access reader

About this research paper

What this paper is about

This article gives a brief overview on the Brazilian traditional medicine, starting from its historical development based on the cultural mixing of indigenous populations, European colonizers, and African slaves. In the sequence, it analyzes some features that contributed to the gradual loss of interest on medicinal plants in Brazil, a process started in the 1950s, and recent initiatives undertaken to valuate the Brazilian traditional medicine. Furthermore, it highlights some drugs developed from or based on constituents of the Brazilian biodiversity and traditional knowledge, which are globally employed, and the perspectives for new drugs development. It also discusses the sanitary requirements currently adopted in Brazil for the development and registration of medicinal products based on the Brazilian biodiversity and associated traditional knowledge, as well as the impact of new technologies. In addition, it is presented a discussion on the regulatory framework to access to genetic heritage and associated traditional knowledge in Brazil, along with its impact on the development of pharmaceutical products. Finally, some attempts are made to indicate the possible causes that limit the development of products based on the genetic heritage of Brazilian plants and associated traditional knowledge.

Why it matters

OpenAlex reports 29 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This article gives a brief overview on the Brazilian traditional medicine, starting from its historical development based on the cultural mixing of indigenous populations, European colonizers, and African slaves. In the sequence, it analyzes some features that contributed to the gradual loss of interest on medicinal plants in Brazil, a process started in the 1950s, and recent initiatives undertaken to valuate the Brazilian traditional medicine. Furthermore, it highlights some drugs developed from or based on constituents of the Brazilian biodiversity and traditional knowledge, which are globally employed, and the perspectives for new drugs development. It also discusses the sanitary requirements currently adopted in Brazil for the development and registration of medicinal products based on the Brazilian biodiversity and associated traditional knowledge, as well as the impact of new technologies. In addition, it is presented a discussion on the regulatory framework to access to genetic heritage and associated traditional knowledge in Brazil, along with its impact on the development of pharmaceutical products. Finally, some attempts are made to indicate the possible causes that limit the development of products based on the genetic heritage of Brazilian plants and associated traditional knowledge.

Key concepts: Traditional knowledge, Indigenous, Biodiversity, Traditional medicine, Process (computing), Cultural heritage, Geography, Environmental planning

Related papers

Back to paper searchBrowse research topicsOriginal source
Brazilian traditional medicine: Historical basis, features and potentialities for pharmaceutical development — Research Paper | ScholarLens